Circulating antibodies to MUC1 are associated with a favorable prognosis in pancreatic cancer [16], while expression of MUC1 indicates a poor prognosis in pancreatobiliary pancreatic head tumors [17]. This evidence concerns the gene MUC1 and pancreatic neoplasm.